Aclarion, Inc. (NASDAQ:ACON – Get Free Report)’s share price shot up 0.8% during trading on Tuesday . Weiss Ratings raised Aclarion from a “sell (e)” rating to a “sell (e+)” rating in a research report on Wednesday. Wall Street Zen raised shares of Aclarion from a “sell” rating to a “hold” rating in a research report on Saturday, June 20th. Aclarion (NASDAQ:ACON – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. Aclarion Company Profile(Get Free Report)Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States.